Dipak K. Das. Dipak Kumar Das (1947 – September 19, 2013[1]) was the director of the Cardiovascular Research Center at the University of Connecticut Health Center in Farmington.
Das is known for his work on the beneficial properties of resveratrol, which is found in red wine,[2] but at least twenty of his research papers have been retracted.[3][4][5] On January 11, 2012 the University of Connecticut Health Center announced that a review board has found Das guilty of 145 counts of fabrication or falsification of data. The three-year investigation examined more than seven years of activity in Das’s lab, and centered on Western blot results that had been manipulated and used in published papers. The investigation into Das was sparked by an anonymous allegation of research irregularities in 2008.[4][5][6][7] In May 2012, Das was fired from both positions at the University of Connecticut Health Center.[8] He then sued for $35 million in damages, citing libel.[8] Biography[edit] References[edit]
Scientific Journals Notified Following Research Misconduct Investigation. An extensive research misconduct investigation has led the University of Connecticut Health Center to send letters of notification to 11 scientific journals that had published studies conducted by a member of its faculty.
Dipak K. Das, Ph.D., a professor in the Department of Surgery and director of the Cardiovascular Research Center, was at the center of a far-reaching, three-year investigation process that examined more than seven years of activity in Das’s lab. “We have a responsibility to correct the scientific record and inform peer researchers across the country,” said Philip Austin, interim vice president for health affairs. The investigation was sparked by an anonymous allegation of research irregularities in 2008. The comprehensive report, which totals approximately 60,000 pages, concludes that Das is guilty of 145 counts of fabrication and falsification of data. The UConn Health Center worked closely with the U.S.
The journals notified by the Health Center are: Fraud Charges for Dipak K. Das, a University of Connecticut Researcher. Peter Morenus/University of Connecticut, via Associated Press Dipak K.
Das in 2006. Fraud allegations against him, if verified, seem unlikely to affect the field of resveratrol research itself, because his work was peripheral to its central principles. Many of the articles reported positive effects from , an ingredient of red wine thought to promote longevity in laboratory animals. The charges, if verified, seem unlikely to affect the field of resveratrol research itself, because Dr. The significance of the case seems more to reflect on the general system of apportioning research money. The agency that granted the funds was the National Heart, Lung and Blood Institute.
The investigation of Dr. According to a 60-page summary of the report, Dr. UConn resveratrol researcher Dipak Das fingered in sweeping misconduct case. Das, via UConn The University of Connecticut, in what clearly seems like an attempt to get ahead of damaging news, has announced an “extensive” investigation into research misconduct involving one of its scientists, Dipak K.
Das. According to a press release, the university has notified 11 journals that published Das’ work about the alleged fraud. One area of interest for Das, a government-funded professor of surgery and director of the Cardiovascular Research Center, has been resveratrol, a substance in red wine that has allegedly been linked to improved cardiac health. The university touted some of his early efforts in this field. [Please also see our update posted Thursday.] Here’s what the release has to say: Resveratrolprof blijkt fraudeur - Chemisch2Weekblad. De tijdschriften in kwestie zijn inmiddels formeel op de hoogte gebracht.
Tegen Das loopt een ontslagprocedure. Volgens collega-wetenschappers betekent het nadrukkelijk niet dat het toch al controversiële resveratrol-verhaal nu meteen de prullenbak in kan. Das lijkt een beetje een tweederangswetenschapper te zijn geweest die handig voortbouwde op het werk van anderen. “Ik heb moeten nazoeken wie hij is. Zijn publicaties verschenen vooral in gespecialiseerde bladen”, zegt resveratrol-expert David Sinclair (Harvard Medical School) in het dagblad The New York Times. Waarbij moet worden aangetekend dat de resveratrolbranche Das wel degelijk voor propagandadoeleinden inzette. Volgens The New York Times is de affaire echter vooral een klap voor de manier waarop in de VS onderzoeksgeld wordt besteed. De universiteit komt tot haar conclusies na een onderzoek dat in januari 2009 begon, na een anonieme tip.
Amerikaanse hoogleraar pleegt fraude. De Amerikaanse hoogleraar Dipak K.
Das, werkzaam aan de University of Connecticut, heeft op grote schaal gefraudeerd bij een onderzoek naar het verband tussen gezondheid en het drinken van rode wijn. Er zouden minstens 26 artikelen, verspreidt over 11 verschillende wetenschapsbladen verzonnen zijn. Op haar site meldt de universiteit dat de tijdschriften inmiddels zijn ingelicht. Das verrichte onderzoek naar resveratrol, een antioxidant die veel voorkomt in rode wijn en volgens Das goed zou zijn voor hart en bloedvaten.
In totaal heeft de onderzoeker bijna 600 artikelen gepubliceerd gedurende zijn carrière, waarvan er 117 zijn gewijd aan de effecten van resveratrol.